Fisher Wallace Laboratories LLC

Form 483 issued March 1, 2016 · New York, New York

Inspection
Feb 17 – Mar 1, 2016
Observations
5
Pages
4
FEI number
3006258094

In short: On March 1, 2016, FDA issued a Form 483 with 5 observations to Fisher Wallace Laboratories LLC in New York, New York (FEI 3006258094) after an inspection that ran Feb 17 – Mar 1, 2016. The investigators were Andrew Garufi and Edouard Viard. Most observations concern cAPA and production & process controls.

At a glance

CAPA and production & process controls account for 4 of 5 observations.

CAPA2
Production & process controls2
Records & documents1

What FDA observed

Preview: the opening words of each observation
  1. 01

    An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of…

  2. 02

    Corrective and preventive action activities and/or results…

  3. 03

    Procedures or instructions for performing servicing activities and verifying that servicing meets specified requirements have…

  4. 04

    A device history record…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Fisher Wallace Laboratories LLC?

FDA listed 5 observations on this Form 483, mostly about cAPA, production & process controls and records & documents. The opening words of each observation are shown on this page.

Who inspected Fisher Wallace Laboratories LLC?

Andrew Garufi and Edouard Viard are named on this Form 483, for the inspection of Feb 17 – Mar 1, 2016. Each investigator has a profile showing what they cite most.

When was Fisher Wallace Laboratories LLC inspected by FDA?

The inspection ran Feb 17 – Mar 1, 2016, and the Form 483 is dated March 1, 2016.

How do I get the full Form 483 for Fisher Wallace Laboratories LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free